Skip to main content
. 2014 May 23;14:287. doi: 10.1186/1471-2334-14-287

Table 1.

Distribution of the main infectious agents isolated in 268 ascitic fluid samples during the period 20102011

  Total (n = 268) (n,%) Ascitic neutrophil count (median, IQR) Non-nosocomial episodes (n = 109) (n,%) Nosocomial episodes (n = 159) (n,%) p 1 SBP (n = 57) (n,%) Bacterascites (n = 140) (n,%) p 2 With FQ prophylaxis (n = 27) (n,%) Without FQ prophylaxis (n = 241) (n,%) p 3
Streptococcus (other than S. pneumoniae)
33 (12.3%)
70 (21–150)
17 (15.6%)
16 (10.1%)
0.18
5 (8.8%)
18 (12.9%)
0.42
2 (7.4%)
31 (31.9%)
0.41
Streptococcus pneumoniae
4 (1.5%)
955 (200–1710)
4 (3.7%)
0 (0.0%)
0.01
1 (1.8%)
1 (0.7%)
0.51
0 (0.0%)
4 (1.7%)
0.50
Enterococcus sp.
65 (24 .3%)
75 (25–565)
15 (13.8%)
50 (31.4%)
0.0009
13 (22.8%)
31 (22.1%)
0.92
13 (48.1%)
52 (21.6%)
0.02
Staphylococcus aureus
7 (2.6%)
392 (18–815)
6 (5.5%)
1 (0.6%)
0.01
0 (0.0%)
0 (0.0%)
-
1 (3.7%)
6 (2.5%)
0.71
Coagulase negative Staphylococcus
73 (27.2%)
63 (8–155,5)
25 (22.9%)
48 (30.2%)
0.19
13 (22.8%)
47 (33.6%)
0.14
4 (14.8%)
69 (28.6%)
0.13
Gram positive cocci
174 (64.9%)
77 (10–310)
67 (61.5%)
107 (67.3%)
0.33
32 (56.1%)
91 (65.0%)
0.24
20 (74.7%)
154 (63.9%)
0.29
Escherichia coli
48 (17.9%)
129 (86–830)
20 (18.3%)
28 (17.6%)
0.88
15 (26.3%)
21 (15.0%)
0.06
3 (11.1%)
45 (18.7%)
0.33
Klebsiella sp.Enterobacter sp. Serratia sp.
29 (10.8%)
92 (58–549)
10 (9.2%)
19 (11.9%)
0.47
5 (8.8%)
10 (7.1%)
0.70
6 (22.2%)
23 (9.5%)
0.04
Pseudomonas sp.
9 (3.4%)
59 (44–670)
0 (0.0%)
9 (5.7%)
0.01
0 (0.0%)
5 (3.6%)
0.15
0 (0.0%)
9 (3.7%)
0.31
Gram negative rods
91 (34.0%)
100 (66–660)
32 (29.4%)
59 (37.1%)
0.18
23 (40.4%)
39 (27.9%)
0.09
9 (33.3%)
82 (34.0%)
0.94
Anaerobes
11 (4.1%)
112 (12–500)
8 (7.3%)
3 (1.9%)
0.03
2 (3.5%)
4 (2.9%)
0.81
0 (0.0%)
11 (4.6%)
0.26
Fungi 7 (2.6%) 52 (30–55) 2 (1.8%) 5 (3.1%) 0.51 0 (0.0%) 3 (2.1%) 0.27 0 (0.0%) 7 (2.9%) 0.37

Not all the infectious agents are listed in this table. Since several agents were isolated in the same sample of ascitic fluid, the total may exceed 100%.

1comparison between non-nosocomial and nosocomial episodes.

2comparison between SBP and bacterascites.

3comparison between episodes with and without fluoroquinolone (norfloxacine) prophylaxis.